Panacea Biotec forms research alliance with US-based Apotex

Panacea Biotec has entered into a strategic alliance with Apotex Inc for research, development, license and supply of two drug delivery-based generic products for US, Canada, Australia and New Zealand.Both companies intend to expand the scope of the alliance by adding new drug delivery based complex generic products to the collaboration.
 
Panacea Biotec will undertake product development and will manufacture and supply the products to Apotex, while Apotex will be responsible for regular affairs, Hatch Waxman litigation and commercialisation activities in the territories, the company said in a statement.